book now
Logo&nsbp;
CO-LOCATED EVENTS
NextPrevious

Session

How can organizations effectively challenge the status quo in HR and embrace innovative approaches to new work

02 | CHALLENGE YOUR PEERS

Thursday, March 21

05:20 PM - 06:20 PM

Live in Chicago

Less Details

  • How can organizations create a culture that encourages HR professionals to challenge traditional practices and explore innovative solutions to adapt to the changing nature of work?
  • How can HR departments leverage emerging technologies and data analytics to redefine their roles in talent acquisition, development, and management while adapting to the demands of the new work landscape?
  • How can organizations ensure that diversity, equity, and inclusion are integrated into their HR strategies as they challenge the status quo and transition to new work paradigms?
  • How can HR leaders effectively communicate and gain buy-in from employees and executives when implementing new HR and work-related initiatives that challenge conventional norms?
  • How can organizations measure the success of their efforts to challenge the status quo in HR and incorporate innovative approaches to new work, and what key performance indicators should they use to gauge their progress?

Speaker

Isabel Belanger

Vice President Talent and Culture, Sygnature Discovery
Join Isabel Belanger
Book Now!

Company

Sygnature Discovery

http://www.sygnaturediscovery.com
Sygnature Discovery is a world-leading integrated drug discovery Contract Research Organisation, with over 1000 staff from 53 nationalities, including 900 scientists working on drug discovery programmes. Founded in 2004, we have delivered over 40 pre-clinical compounds, 21 clinical compounds, and our scientists are named on over 170 patent applications. We partner with global pharma, biotech, and NFP organizations, providing integrated drug discovery services from target identification through to candidate nomination. Our co-located teams are experts in protein science, chemistry, computational chemistry, in vitro biology, pharmacology, DMPK, form and formulation services, and project management, with a core therapeutic focus on oncology, inflammation and immunology, as well as neuroscience, metabolic diseases, respiratory, infectious diseases and fibrotic diseases.
Get Agenda
Book Now

NextPrevious